Income Tax Expense (Benefit) of THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. from 31 Dec 2021 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2021 to 30 Jun 2024.
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2024 was $800, unchanged year-over-year.
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. annual Income Tax Expense (Benefit) for 2023 was $2,250, a 41% increase from 2022.
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. annual Income Tax Expense (Benefit) for 2022 was $1,600, a 100% increase from 2021.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$800	$0	0%	01 Apr 2024	30 Jun 2024	10-Q	19 Aug 2024	2024	Q2
Q2 2023	$800			01 Apr 2023	30 Jun 2023	10-Q	19 Aug 2024	2024	Q2
Q3 2022	$800			01 Jul 2022	30 Sep 2022	10-Q	14 Nov 2023	2023	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$2,250	+$650	+41%	01 Jan 2023	31 Dec 2023	10-K	17 Apr 2024	2023	FY
2022	$1,600	+$800	+100%	01 Jan 2022	31 Dec 2022	10-K	17 Apr 2024	2023	FY
2021	$800			01 Jan 2021	31 Dec 2021	10-K	29 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.